Yali Qu
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- RNA modifications and cancer 2
- Co-authors
- Mou Li (3 shared papers)Bin Song (5 shared papers)Yingzhen Zhang (1 shared paper)Gavin Hamilton (1 shared paper)Qingyang Huang (2 shared papers)Xiaojing Zou (1 shared paper)Yu Yuan (1 shared paper)You Shang (1 shared paper)
- Journals
- European Radiology (4 papers)European Journal of Radiology (2 papers)Science Immunology (1 paper)Cardiovascular Diabetology (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yali Qu
19 papers receiving 250 citations
Peers
Comparison fields: 5 of 46
- Internal Medicine 19
- Hepatology 30
- Infectious Diseases 50
- Epidemiology 60
- Health Informatics 2
Countries citing papers authored by Yali Qu
This map shows the geographic impact of Yali Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Qu more than expected).
Fields of papers citing papers by Yali Qu
This network shows the impact of papers produced by Yali Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Qu. The network helps show where Yali Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yali Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 52 | |
| 2 | 2020 | 32 | |
| 3 | 2017 | 26 | |
| 4 | 2013 | 26 | |
| 5 | 2024 | 24 | |
| 6 | 2022 | 17 | |
| 7 | 2022 | 15 | |
| 8 | 2020 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2010 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2019 | 7 | |
| 13 | 2020 | 6 | |
| 14 | [Epidemiological status and risk factors of hyperuricemia in rural area of the Three Gorges]. | 2013 | 6 |
| 15 | 2025 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2025 | 1 | |
| 18 | [Type 2 diabetes prevalence and its risk factors among migrants and nonmigrants aged 35 years and older in Three Gorge Dam area, China]. | 2012 | 1 |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Yali Qu
Yali Qu is a scholar working on Infectious Diseases, Molecular Biology, Hepatology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 20 papers that have together received 252 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), interferon and immune responses (2 papers), Cardiovascular Disease and Adiposity (2 papers), Immune Cell Function and Interaction (2 papers), RNA modifications and cancer (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper) and Advanced X-ray and CT Imaging (1 paper). The work is most often cited by research in Internal Medicine (19 citations), Hepatology (30 citations), Infectious Diseases (50 citations), Epidemiology (60 citations) and Health Informatics (2 citations). Yali Qu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mou Li, Bin Song, Yingzhen Zhang, Gavin Hamilton, Qingyang Huang, Xiaojing Zou, Yu Yuan, You Shang, Chaolin Huang and Meng Gao. Their work appears in journals such as European Radiology, European Journal of Radiology, Science Immunology, Cardiovascular Diabetology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.